CT2YYZZ
Tomographic (Tomo) Nuclear Medicine Imaging Urinary System to None with None, Other Radionuclide Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | C Nuclear Medicine |
| Body System | T Urinary System |
| Operation | 2 Tomographic (Tomo) Nuclear Medicine Imaging |
| Body Part | Y Urinary System |
| Approach | Y Other Radionuclide |
| Device | Z None |
| Qualifier | Z None |
Operation Definition
Introduction of radioactive materials into the body for three dimensional display of images developed from the capture of radioactive emissions
Procedure Overview
Tomographic nuclear medicine imaging of the urinary system uses a radioactive tracer, most often technetium-99m DMSA or MAG3, injected into a vein and tracked by a rotating gamma camera to build a three-dimensional picture of the kidneys. Unlike a flat, single-angle scan, the tomographic (SPECT) technique lets a physician see depth and separate overlapping structures, which is especially useful for spotting scarring, focal infection, or areas of reduced kidney function that a planar image might hide behind normal tissue.
This family of procedures is typically ordered to evaluate suspected pyelonephritis, renal scarring after recurrent urinary tract infections in children, congenital abnormalities such as a duplicated collecting system, or to assess split function between two kidneys before a planned nephrectomy. Because the tracer concentrates in functioning renal tubular tissue, areas that fail to take it up appear as defects, pointing to damaged or nonfunctioning tissue.
The patient receives an injection and then waits, often a few hours, before lying still on a scanning table while the camera rotates around the abdomen and flank.
Anatomy & Axis Detail
Urinary System
When tomographic acquisition is applied to the urinary system as an unspecified or composite region rather than to named component organs, it reflects a study designed to survey renal and urinary tract function volumetrically without the report singling out the kidneys, ureters, or bladder as separately coded targets. This is typically the case in broader functional surveys where the goal is to characterize tracer clearance and drainage dynamics across the whole tract in three dimensions, improving on planar imaging's tendency to superimpose structures at different depths. The tomographic technique is particularly valuable here because it can reveal asymmetric or delayed transit that a flat image would average out. Coders should confirm from the procedure note that the urinary system was addressed as a unified target rather than through separately documented organ-specific tomographic studies.
Radionuclide: Other Radionuclide
Other Radionuclide is used when a nuclear medicine study employs a radioactive tracer that does not correspond to one of the specifically named isotope values in this axis, such as an uncommon or newer radiopharmaceutical. It functions as a catch-all so the procedure can still be coded precisely by section and root operation even when the exact tracer lacks its own dedicated code value.
Coding & Documentation
Coders assign these codes when the record documents a SPECT or SPECT/CT acquisition of the kidneys or urinary tract following radiotracer administration, not a simple planar renal scan. The operative or imaging report should state the tracer used, confirm rotational or tomographic acquisition, and identify the urinary structure imaged. A frequent error is defaulting to the planar imaging root operation because the two are billed similarly in other coding systems; ICD-10-PCS requires the coder to read the technique line closely, since planar and tomographic renal studies fall under different root operations despite sharing the same tracer and clinical indication. Another recurring mistake is coding the radiopharmaceutical administration separately when it is already captured as the qualifier or device value within the nuclear medicine table, leading to duplicate reporting.